Top Markets
#1 PulseChain PulseChain +45.01%
#2 SkyAI SkyAI +17.01%
#3 Orochi Network Orochi Network +10.19%
#4 Pump.fun Pump.fun +9.55%
#5 Unit Pump Unit Pump +9.55%
#6 eCash eCash +9.31%
#7 Fake World Assets Fake World Assets +8.82%
#8 OPENLOOT OPENLOOT +8.48%
#9 Meteora Meteora +8.22%
#10 Glidr Glidr +8.12%
Coin of the day
PulseChain PulseChain
Cài đặt
Ngôn ngữ
TIếNG VIệT
Tiền tệ
USD
Chủ đề
Marinus Pharmaceuticals, Inc. Marinus Pharmaceuticals, Inc.

Marinus Pharmaceuticals, Inc.

MRNS
Xếp hạng trong cổ phiếu #28040
Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated... Marinus Pharmaceuticals, Inc. is a specialized biopharmaceutical firm dedicated to the development and commercialization of therapeutic solutions for individuals suffering from rare genetic epilepsies and other seizure-related conditions. The company's primary commercialized product is ZTALMY, an oral suspension specifically designed to manage seizures associated with cyclin-dependent kinase-like 5 deficiency disorder (CDD). This medication is prescribed for both adult and pediatric patient populations, suitable for use in acute and chronic care settings, and can be administered either in-patient or by the patient themselves. ZTALMY exerts its effect by targeting synaptic and extrasynaptic GABAA receptors, a mechanism that also suggests potential anticonvulsant, antidepressant, and anxiolytic benefits. Beyond ZTALMY, Marinus is actively progressing ganaxolone through development, an investigational therapy aimed at various genetic epileptic conditions such as PCDH19-related epilepsy, tuberous sclerosis complex, and Lennox-Gastaut Syndrome, with additional exploration for depressive disorders. The company maintains strategic alliances, including licensing agreements with Purdue Neuroscience Company and CyDex Pharmaceuticals, Inc., as well as a collaborative partnership with Orion Corporation. Marinus Pharmaceuticals was established in 2003 and operates from its corporate headquarters in Radnor, Pennsylvania.
Giá cổ phiếu
$0.55
Đồng bộ lần cuối: 2025-02-11
Vốn hóa thị trường
$28.90M
Thay đổi (1 ngày)
0.00%
Thay đổi (1 năm)
0.00%
Quốc gia
US
Giao dịch Marinus Pharmaceuticals, Inc. (MRNS)

Danh mục

Healthcare
Doanh thu của Marinus Pharmaceuticals, Inc. (MRNS)
Doanh thu vào Sep 2024 TTM: $31.47M
Theo các báo cáo tài chính gần đây của Marinus Pharmaceuticals, Inc., doanh thu hiện tại của công ty (TTM) là $31.47M. Trong năm 2022, công ty đạt doanh thu $25.48M tăng so với doanh thu năm 2021, là $15.35M. Doanh thu là tổng số tiền công ty tạo ra từ việc bán hàng hóa hoặc dịch vụ. Không giống như lợi nhuận, doanh thu không trừ chi phí.
Lịch sử doanh thu của Marinus Pharmaceuticals, Inc. từ 2012 đến 2026
Doanh thu vào cuối mỗi năm
Năm Doanh thu Thay đổi
2026 (TTM) $31.47M 1.54%
2023 $30.99M 21.63%
2022 $25.48M 66.03%
2021 $15.35M 793.19%
2020 $1.72M 0.00%
2019 0.00 0.00%
2018 0.00 0.00%
2017 0.00 0.00%
2016 0.00 0.00%
2015 0.00 0.00%
2014 0.00 0.00%
2013 0.00 -100.00%
2012 $100.00K 0.00%
Doanh thu của các công ty hoặc đối thủ tương tự
Công ty Doanh thu Chênh lệch doanh thu Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B 40,020.45%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B 6,980.66%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B 19,035.85%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.70B 49,779.98%
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH